Atherosclerotic Cardiovascular Disease Research

You might qualify for the Atherosclerotic Cardiovascular Disease Research Study!

Heart diseases including Atherosclerotic Cardiovascular Diseases are one of the leading causes of death for men and women in the United States. Despite advancements in medicine and treatments, there is still an unmet need for effective treatments that prevent and manage cardiovascular conditions. Lipoprotein(a) is also known as Lp(a). Lp(a) carries cholesterol (a type of fat) in the blood. If you have a high level of Lp(a), you may have a higher risk of heart disease, heart attack, or stroke.

Revival Research Institute is conducting a clinical research study evaluating the safety and effectiveness of an investigational drug in lowering Lp(a) in blood.

You may be eligible for the Clinical Research Study if you:

• Are 55 years or older, and have certain risk factors for heart disease or stroke
• Or are 18 years or older and already have heart disease or have had a stroke
• Have a high level of Lipoprotein(a) in your blood

This Cardiovascular Disease Research Study will have Cardiologists and doctors gain a better understanding of the condition and observe whether the investigational medication helps lower “bad” cholesterol levels in the body that contribute to heart diseases.

*Participation in the Clinical Trial is completely free of cost and is your choice.

**To participate, fill out the form, and someone from our research staff will call you to see if you are eligible for the Clinical Research Study.

Once you agree to take part in the study, you will be asked to sign an Informed Consent Form that has all the details of the study. The study team will also be there to guide you about the process and your role in the study trials. We highly encourage all our participants to ask as many questions as they’d like before participating. In the end, the decision is all yours whether to take part or walk out of the trial.

Once the consent form is signed and all your questions are answered, you will be assigned to a group by random selection. The two groups in the Cardiovascular Disease Research Study are

• Control group
• Experimental group

The control group is given a placebo medication that does not have an active ingredient. In contrast, the experimental group is the one that is being treated with an actual study drug that has active ingredients. The study team is also unaware of the allocation as it is a double-blind research study, meaning neither the researcher nor the participant knows which treatment or intervention is being given to them.

In case of emergency or any mishap, the information about your study treatment will be revealed to the study doctor.